Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 352 (9122), 93-97
- https://doi.org/10.1016/s0140-6736(98)85011-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Delayed Severe Hypertriglyceridemia from TamoxifenNew England Journal of Medicine, 1997
- Alternative mechanisms of action of anti-oestrogensBreast Cancer Research and Treatment, 1994
- Cardiovascular disease in women.Circulation, 1993
- New Perspective on Cancer of the Contralateral Breast: A Marker for Assessing Tamoxifen as a Preventive AgentJNCI Journal of the National Cancer Institute, 1991
- Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancerBritish Journal of Cancer, 1988
- Severe lipemia induced by tamoxifenCancer, 1986
- TAMOXIFEN AND CONTRALATERAL BREAST CANCERThe Lancet, 1985
- Anti-Oestrogen Action in Experimental Breast CancerRecent Results in Cancer Research, 1980